Industry Roundup: BioLucent, Intermagnetics, Philips, RBMA, Rendoscopy, Varian
BioLucent released an addition to its MammoPad products specifically designed for use with the Dilon 6800 Gamma Camera for use during breast-specific gamma imaging (BSGI) manufactured by Dilon Technologies. The cushion is sized to fit the surface of the Dilon equipment. BSGI is an adjunct diagnostic procedure to mammography where the breast is immobilized for six to 10 minutes per view. MammoPad products can be used to cushion the detector as well as the shield, providing warmth and comfort for patients. The pad’s grip-like effect helps stabilize the breast during the longer duration of imaging necessary for BSGI. The new pad maintains the same attributes and benefits of other MammoPad products. The foam cushion is made of a radiolucent material that does not interfere with imaging of the breast. The cushion received FDA clearance in September.

Intermagnetics shareholders approved the merger with Philips that was originally announced in June. The acquisition is expected to close in Q4. The transaction is still subject to regulatory approval by the European Commission and other requirements. Intermagnetics’ core focus is MRI components, while its subsidiary Invivo provides MR accessories, and Invivo Patient Care sells monitoring and other patient care devices.

In September, Gregory M. Kusiak assumed the office of RBMA (Radiology Business Management Association) president of the Board of Directors. Shannon J. Doyle, the previous president, stepped down from his Board position, though he will remain an active member of RBMA. Kusiak is the practice manager of The Hill Medical Corporation in Pasadena, Calif., and president of CMBS, a full-service practice management firm.

Three-dimensional visualization software provider Rendoscopy gained FDA clearance for its Gentle Colon virtual colonoscopy application.

Varian Medical Systems is exhibiting its latest treatment technology at the 2006 European Society of Therapeutic Radiation Oncologists (ESTRO) meeting in Leipzig, Germany, Oct. 8-ll. The comprehensive ARIA oncology information and image management system, already in clinical use at a number of centers in the United States and Europe, is being demonstrated. This system unifies all administrative, clinical, and financial information for cancer care professionals. ARIA also is designed to work in concert with the company’s Eclipse treatment planning system.